Literature DB >> 9264304

The effect of interleukin-1alpha on outflow facility in rat eyes.

C Kee1, K Seo.   

Abstract

PURPOSE: The authors investigated whether regulation of the trabecular extracellular matrix turnover rate and remodeling plays an important role in decreasing outflow resistance by determining the effect of intracamerally given interleukin-1alpha, a known stimulator of the expression of trabecular matrix metalloproteinases, on outflow facility of albino rat eyes.
MATERIALS AND METHODS: Forty normal albino rats (Sprague-Dawley), weighing 250 to 300 g, were studied. Rats were anesthetized by intraperitoneal pentobarbital sodium (30 mg/kg) injection. The rats were separated into four groups and given 5, 10, 25, or 50 units of interleukin-1alpha injected intracamerally in one eye. Bovine serum albumin in phosphate-buffered saline, which was used to dissolve the interleukin-1alpha, was injected in the fellow eye as a control. Outflow facility was measured by two-level constant pressure perfusion 1, 3, and 7 days after injection.
RESULTS: The eyes treated with 50 units of interleukin-1alpha showed a statistically significant increase of outflow facility by 37% compared with the contralateral control eyes 3 days after injection, but returned to normal levels in 7 days. The eyes treated with 5, 10, 25, or 50 units of interleukin-1alpha showed outflow facility increases of 12%, 20%, 39%, and 37%, respectively, 3 days after injection.
CONCLUSION: Interleukin-1alpha increased the outflow facility, supporting the hypothesis that regulation of trabecular meshwork extracellular matrix plays a role in trabecular outflow resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264304

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  The Effect of Cumulative Dissipated Energy on Changes in Intraocular Pressure After Uncomplicated Cataract Surgery by Phacoemulsification.

Authors:  Roland Y Lee; Rebecca I Chen; Toshimitsu Kasuga; Qi N Cui; Travis C Porco; Shan C Lin
Journal:  J Glaucoma       Date:  2016-07       Impact factor: 2.503

2.  Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype.

Authors:  N Wang; S K Chintala; M E Fini; J S Schuman
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

3.  Association between IL1A and IL1B polymorphisms and primary open angle glaucoma in a Brazilian population.

Authors:  Mariana B Oliveira; José Paulo C de Vasconcellos; Galina Ananina; Vital P Costa; Mônica B de Melo
Journal:  Exp Biol Med (Maywood)       Date:  2018-09

4.  Ultrasound activates the TM ELAM-1/IL-1/NF-kappaB response: a potential mechanism for intraocular pressure reduction after phacoemulsification.

Authors:  Nan Wang; Shravan K Chintala; M Elizabeth Fini; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

Review 5.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

Review 6.  Biological properties of trabecular meshwork cells.

Authors:  Joshua Z Gasiorowski; Paul Russell
Journal:  Exp Eye Res       Date:  2008-08-26       Impact factor: 3.467

7.  Glaucomatous MYOC mutations activate the IL-1/NF-κB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells.

Authors:  Tatsuo Itakura; Donna M Peters; M Elizabeth Fini
Journal:  Mol Vis       Date:  2015-09-17       Impact factor: 2.367

8.  Outcomes of Complex Cataract Surgery in Patients with Primary Open-angle Glaucoma.

Authors:  Albert R Bargoud; Hardik Parikh; Neil Kalbag; Patricia Greenberg; Albert S Khouri
Journal:  J Curr Glaucoma Pract       Date:  2019 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.